Reply: "Biologics for psoriasis during COVID-19 outbreak"
- PMID: 32283234
- PMCID: PMC7146699
- DOI: 10.1016/j.jaad.2020.04.004
Reply: "Biologics for psoriasis during COVID-19 outbreak"
Comment in
-
Reply to: "Biologics for psoriasis during COVID-19 outbreak".J Am Acad Dermatol. 2020 Jun;82(6):e219. doi: 10.1016/j.jaad.2020.04.014. Epub 2020 Apr 10. J Am Acad Dermatol. 2020. PMID: 32283241 Free PMC article. No abstract available.
Comment on
-
Should biologics for psoriasis be interrupted in the era of COVID-19?J Am Acad Dermatol. 2020 May;82(5):1217-1218. doi: 10.1016/j.jaad.2020.03.031. Epub 2020 Mar 19. J Am Acad Dermatol. 2020. PMID: 32199889 Free PMC article. No abstract available.
References
-
- Sarzi-Puttini P., Giorgi V., Sirotti S. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin Exp Rheumatol. 2020;38(2):337–342. - PubMed
-
- Bashyam A.M., Feldman S.R. Should patients stop their biologic treatment during the COVID-19 pandemic. J Dermatolog Treat. 2020:1–2. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical